Sarcopenia, adiposity and large discordance between cystatin C and creatinine‐based estimated glomerular filtration rate in patients with cancer
Journal of Cachexia, Sarcopenia and Muscle · 2024-06 · 15 (3) · 1187-1198
DOI: 10.1002/jcsm.13469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 22.04.2024. Verfasst von Paul E Hanna und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. Hauptthemen laut MEDLINE: Cystatin C, Sarcopenia, Glomerular Filtration Rate, Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Creatinine‐based estimated glomerular filtration rate (eGFR CRE ) may overestimate kidney function in patients with sarcopenia. While cystatin C‐based eGFR (eGFR CYS ) is less affected by muscle mass, it may underestimate kidney function in patients with obesity. We sought to evaluate the relationship between body composition defined by computed tomography (CT) scans and discordance between creatinine, eGFR CRE and eGFR CYS in adult patients with cancer.
Methods
This study is a cross‐sectional study of consecutive adults with cancer with an abdominal CT scan performed within 90 days of simultaneous eGFR CRE and eGFR CYS measurements between May 2010 and January 2022. Muscle and adipose tissue cross‐sectional areas were measured at the level of the third lumbar vertebral body using a validated deep‐learning pipeline. CT‐defined sarcopenia was defined using independent sex‐specific cut‐offs for skeletal muscle index ( 50% lower than eGFR CRE . The odds of eGFR discordance were estimated using multivariable logistic regression modelling. Unadjusted spline regression was used to evaluate the relationship between skeletal muscle index and the difference between eGFR CYS and eGFR CRE .
Results
Of the 545 included patients (mean age 63 ± 14 years, 300 [55%] females, 440 [80.7%] non‐Hispanic white), 320 (58.7%) met the criteria for CT‐defined sarcopenia, and 136 (25%) had high adiposity. A total of 259 patients (48%) had >30% eGFR discordance, and 122 (22.4%) had >50% eGFR discordance. After adjustment for potential confounders, CT‐defined sarcopenia and high adiposity were both associated with >30% eGFR discordance (adjusted odds ratio [aOR] 1.90, 95% confidence interval [CI] 1.12–3.24; aOR 2.01, 95% CI 1.15–3.52, respectively) and >50% eGFR discordance (aOR 2.34, 95% CI 1.21–4.51; aOR 2.23, 95% CI 1.19–4.17, respectively). A spline model demonstrated that as skeletal muscle index decreases, the predicted difference between eGFR CRE and eGFR CYS widens considerably.
Conclusions
CT‐defined sarcopenia and high adiposity are both independently associated with large eGFR discordance. Incorporating valuable information from body composition analysis derived from CT scans performed as a part of routine cancer care can impact the interpretation of GFR estimates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
- Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
- Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
- Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
- Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
ORCID-Profile: Paul E Hanna
Förderung
- NIDDK NIH HHS
- NIH HHS
- NHLBI NIH HHS
- NIH/NIA
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Hanna, P. E., Ouyang, T., Tahir, I., Katz-Agranov, N., Wang, Q., Mantz, L., Strohbehn, I., Moreno, D., Harden, D., Dinulos, J. E., Cosar, D., Seethapathy, H., Gainor, J. F., Shah, S. J., Gupta, S., Leaf, D. E., Fintelmann, F. J., & Sise, M. E. (2024). Sarcopenia, adiposity and large discordance between cystatin C and creatinine‐based estimated glomerular filtration rate in patients with cancer. Journal of Cachexia, Sarcopenia and Muscle, 15(3), 1187-1198. https://doi.org/10.1002/jcsm.13469
Vancouver
Hanna PE, Ouyang T, Tahir I, Katz-Agranov N, Wang Q, Mantz L, et al. Sarcopenia, adiposity and large discordance between cystatin C and creatinine‐based estimated glomerular filtration rate in patients with cancer. Journal of Cachexia, Sarcopenia and Muscle. 2024;15(3):1187-1198. doi:10.1002/jcsm.13469
BibTeX
@article{Hanna2024,
author = {Hanna, Paul E and Ouyang, Tianqi and Tahir, Ismail and Katz-Agranov, Nurit and Wang, Qiyu and Mantz, Lea and Strohbehn, Ian and Moreno, Daiana and Harden, Destiny and Dinulos, James E and Cosar, Duru and Seethapathy, Harish and Gainor, Justin F and Shah, Sachin J and Gupta, Shruti and Leaf, David E and Fintelmann, Florian J and Sise, Meghan E},
title = {Sarcopenia, adiposity and large discordance between cystatin C and creatinine‐based estimated glomerular filtration rate in patients with cancer},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2024},
volume = {15},
number = {3},
pages = {1187--1198},
doi = {10.1002/jcsm.13469}
}
EUVIMED